Screener
Trevi Therapeutics, Inc. TRVI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Number of Option Shares | Weighted Average Exercise Price |
|---|---|---|
| Outstanding as of December 31, 2025 | 9,301,618 | $3.63 |
| Granted | 3,176,250 | $10.66 |
| Exercised | (104,992) | $2.11 |
| Forfeited | (331,190) | $6.74 |
| Expired | — | — |
| Outstanding as of March 31, 2026 | 12,041,686 | $5.41 |
| Options exercisable as of March 31, 2026 | 5,918,559 | $3.46 |
| Options unvested as of March 31, 2026 | 6,123,127 | $7.29 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, expirations in period?
- Trevi Therapeutics, Inc. (TRVI) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 0 in Q1 2026.
- What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?
- The count of stock options that reached the end of their contractual term without being exercised, resulting in their expiration. This reflects the historical utilization of equity incentive plans and the potential for future dilution.
Ask your AI about Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, expirations in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude